Company Overview

Detailed company information

Basic Information

Ticker: AGIO

Country: US

Headquarter: Cambridge, MA

Employees: 540

Financial Information

Market Cap: $2 Billion

Currency: USD

Sector: Healthcare

Industry: Biotechnology

Stock Price Chart

Stock Data provided by Financial Modeling Prep

About Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to the research and advancement of new treatments, specifically targeting cellular metabolism and related biological fields. The company's offerings include PYRUKYND (mitapivat), a medication designed to activate both wild-type and various mutated pyruvate kinase (PK) enzymes, used in the management of hemolytic anemias. Additionally, Agios is developing AG-946, which is currently undergoing Phase I clinical studies for treating hemolytic anemias and other diseases. Established in 2007, the company's main office is located in Cambridge, Massachusetts.

Last Updated: Sep 2026

Here's what you can ask

Earnings Transcripts

Latest

Earnings Transcript for 2026 - Q2Released: Jul 30, 2026

Earnings Transcript for 2026 - Q1Released: Apr 29, 2026

Earnings Transcript for 2025 - Q4Released: Feb 12, 2026

Earnings Transcript for 2025 - Q3Released: Oct 30, 2025

Earnings Transcript for 2025 - Q2Released: Jul 31, 2025

Earnings Transcript for 2025 - Q1Released: May 01, 2025

Earnings Transcript for 2024 - Q4Released: Feb 13, 2025

Earnings Transcript for 2024 - Q3Released: Oct 31, 2024

Earnings Transcript for 2024 - Q2Released: Aug 01, 2024

Earnings Transcript for 2024 - Q1Released: May 02, 2024

Earnings Transcript for 2023 - Q4Released: Feb 15, 2024

Earnings Transcript for 2023 - Q3Released: Nov 02, 2023

Earnings Transcript for 2023 - Q2Released: Aug 03, 2023

Earnings Transcript for 2023 - Q1Released: May 04, 2023

Earnings Transcript for 2022 - Q4Released: Feb 23, 2023

Earnings Transcript for 2022 - Q3Released: Nov 04, 2022

Earnings Transcript for 2022 - Q2Released: Aug 07, 2022

Earnings Transcript for 2022 - Q1Released: May 05, 2022

Earnings Transcript for 2021 - Q4Released: Feb 24, 2022

Earnings Transcript for 2021 - Q3Released: Nov 03, 2021

Earnings Transcript for 2021 - Q2Released: Jul 30, 2021

Earnings Transcript for 2021 - Q1Released: Apr 29, 2021

Earnings Transcript for 2020 - Q4Released: Feb 25, 2021

Earnings Transcript for 2020 - Q3Released: Nov 05, 2020